Видео ютуба по тегу Opus Genetics

Opus Genetics запускает клинические испытания генной терапии для лечения бестселлера
Opus Genetics запускает клинические испытания генной терапии для лечения бестселлера
Opus Genetics Company Webcast @ Lytham Partners Spring 2025 Investor Conference
Opus Genetics Company Webcast @ Lytham Partners Spring 2025 Investor Conference
Opus Genetics
Opus Genetics
Opus Genetics - Sally Tucker, PhD, SVP, Head of Clinical Development
Opus Genetics - Sally Tucker, PhD, SVP, Head of Clinical Development
Opus Genetics: My Concern About This $1.6M Gene Therapy Deal
Opus Genetics: My Concern About This $1.6M Gene Therapy Deal
Opus Genetics | Ben Yerxa, PhD, CEO
Opus Genetics | Ben Yerxa, PhD, CEO
LCA5: Community Perspective for Awareness Month - Jami's Story
LCA5: Community Perspective for Awareness Month - Jami's Story
Let's Chat About...Opus Genetics
Let's Chat About...Opus Genetics
Gene therapy offers hope for blindness
Gene therapy offers hope for blindness
Opus Genetics - Ben Yerxa, PHD
Opus Genetics - Ben Yerxa, PHD
Meet Dr. George Magrath | CEO of Ocuphire (Now Opus Genetics)
Meet Dr. George Magrath | CEO of Ocuphire (Now Opus Genetics)
Eyecelerator @ AAO 2025 | Posterior / Retina Segment Showcase: Opus Genetics
Eyecelerator @ AAO 2025 | Posterior / Retina Segment Showcase: Opus Genetics
Meet Dr. Lilia Koza with Opus Genetics
Meet Dr. Lilia Koza with Opus Genetics
Opus Genetics December 11, 2024, KOL Webinar
Opus Genetics December 11, 2024, KOL Webinar
LCA5 Safety Profile
LCA5 Safety Profile
Opus Genetics 8-K: My Insight on Their 2026 Catalysts
Opus Genetics 8-K: My Insight on Their 2026 Catalysts
Opus Genetics' Vision: My Take on This Risky Bet for Gene Therapy Funding
Opus Genetics' Vision: My Take on This Risky Bet for Gene Therapy Funding
Fighting Blindness & Funding The Fight With Opus Genetics' Ben Yerxa, CEO
Fighting Blindness & Funding The Fight With Opus Genetics' Ben Yerxa, CEO
Opus Genetics The Dark Side of Gene Therapy Investments
Opus Genetics The Dark Side of Gene Therapy Investments
Gene Therapy for Inherited Retinal Diseases with Opus Genetics' Dr. George Magrath
Gene Therapy for Inherited Retinal Diseases with Opus Genetics' Dr. George Magrath
Opus Genetics Secures FDA Clearance for Gene Therapy Targeting BEST1 Inherited Retinal Disease
Opus Genetics Secures FDA Clearance for Gene Therapy Targeting BEST1 Inherited Retinal Disease
Opus Genetics Partners with Global RDH12 Alliance for Gene Therapy Breakthrough
Opus Genetics Partners with Global RDH12 Alliance for Gene Therapy Breakthrough
Chardan Ophthalmology Conference Series - Rare Disease ft. Opus Genetics
Chardan Ophthalmology Conference Series - Rare Disease ft. Opus Genetics
The Future of Ophthalmic Gene Therapies as Standard of Care
The Future of Ophthalmic Gene Therapies as Standard of Care